USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells
Lu, Ruitao, Wu, Guangxian, Chen, Meiling, Ji, Dongmei, Liu, Yonghong, Zhou, Grace Guoying, Fu, Wenmin
Published in Molecular therapy. Oncolytics (17.12.2021)
Published in Molecular therapy. Oncolytics (17.12.2021)
Get full text
Journal Article
Termination of Transcription of LAT Increases the Amounts of ICP0 mRNA but Does Not Alter the Course of HSV-1 Infection in Latently Infected Murine Ganglia
Jiang, Haifang, Wu, Jiaming, Liu, Xianjie, Lu, Ruitao, Zhou, Manling, Chen, Meiling, Liu, Yonghong, Zhou, Grace Guoying, Fu, Wenmin
Published in Virologica Sinica (01.04.2021)
Published in Virologica Sinica (01.04.2021)
Get full text
Journal Article
A Hsp40 chaperone protein interacts with and modulates the cellular distribution of the primase protein of human cytomegalovirus
Pei, Yonggang, Fu, Wenmin, Yang, Ed, Shen, Ao, Chen, Yuan-Chuan, Gong, Hao, Chen, Jun, Huang, Jun, Xiao, Gengfu, Liu, Fenyong
Published in PLoS pathogens (01.11.2012)
Published in PLoS pathogens (01.11.2012)
Get full text
Journal Article
Intravenous (IV) infusion of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, as monotherapy in advanced solid tumors: Preliminary results from an ongoing phase 1/2a study
Niu, Jiaxin, Barve, Minal A., Spira, Alexander I., Edenfield, William Jeffery, Pang, Weijia, Fu, Wenmin, Lu, Yingxin, McKean, Meredith
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
IFNgamma-inducible CXCL10/CXCR3 axis alters the sensitivity of HEp-2 cells to ionizing radiation
Lin, Yunting, Lu, Ruitao, Hou, Jingmei, Zhou, Grace Guoying, Fu, Wenmin
Published in Experimental cell research (01.01.2021)
Published in Experimental cell research (01.01.2021)
Get full text
Journal Article
A phase I/IIa study to assess the safety, tolerability, PK, and PD of T3011, a genetically modified oncolytic virus (OVs) administered intravenously (IV) in patients with advanced solid tumors
Li, Ziming, Zhang, Jian, Zhang, Shuang, Zheng, Li, Zhang, Zhiye, Wang, Junbin, Hu, Ying, Luo, Su-xia, Pang, Weijia, Fu, Wenmin, Qin, Yanmei, Lu, Shun
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Updated results from an ongoing phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via IT injection as monotherapy or combined with pembrolizumab in advanced solid tumors
Niu, Jiaxin, Kaufman, Howard L., Kichenadasse, Ganessan, Haydon, Andrew Mark, Barve, Minal A., Ganju, Vinod, Buchbinder, Elizabeth Iannotti, Spira, Alexander I., Pang, Weijia, Fu, Wenmin, Zhao, Min, Kirkwood, John M. M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article